Dingemanse; Jasper

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dingemanse; Jasper.The latest application filed is for "dosing regimen for a selective s1p1 receptor agonist".

Company Profile

8.8.11

Dingemanse; Jasper - Allswchill CH
DINGEMANSE; Jasper - Allschwil CH
Dingemanse; Jasper - Allchwil N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]- -2-ethyl-6-methyl-phenox Grant 11,390,615 - Lescop , et al. July 19, 2	2022-07-19
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20210401811 - BROSSARD; Patrick ; et al.	2021-12-30
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20210052555 - DINGEMANSE; Jasper ; et al.	2021-02-25
Crystalline Form Of The Compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]- -2-ethyl-6-methyl-phenoxy}-propane-1,2-diol App 20210024513 - LESCOP; Cyrille ; et al.	2021-01-28
Dosing regimen for a selective S1P.sub.1 receptor agonist Grant 10,857,134 - Dingemanse , et al. December 8, 2	2020-12-08
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]- -2-ethyl-6-methyl-phenoxy}-propane-1,2-diol Grant 10,836,754 - Lescop , et al. November 17, 2	2020-11-17
Dosing regimen for a selective S1P.sub.1 agonist Grant 10,660,880 - Brossard , et al.	2020-05-26
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20190151292 - DINGEMANSE; Jasper ; et al.	2019-05-23
Dosing regimen for a selective S1P.sub.1 receptor agonist Grant 10,251,867 - Brossard , et al.	2019-04-09
Dosing regimen for a selective S1P.sub.1 receptor agonist Grant 10,220,023 - Dingemanse , et al.	2019-03-05
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20180147188 - DINGEMANSE; Jasper ; et al.	2018-05-31
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20170319555 - DINGEMANSE; Jasper ; et al.	2017-11-09
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20150265580 - BROSSARD; PATRICK ; et al.	2015-09-24
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20140315964 - BROSSARD; PATRICK ; et al.	2014-10-23
Dosing Regimen For A Selective S1p1 Agonist App 20140316140 - BROSSARD; PATRICK ; et al.	2014-10-23
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20140303217 - BROSSARD; Patrick ; et al.	2014-10-09
Dosing regimen for a selective S1P1 receptor agonist Grant 8,785,484 - Brossard , et al. July 22, 2	2014-07-22
Dosing Regimen For A Selective S1p1 Receptor Agonist App 20110021581 - Brossard; Patrick ; et al.	2011-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.